CC
ASXC

Centiva Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

Centiva Capital’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,134
Closed -$6K – 1898
2022
Q2 		$6K Buy
+14,134
New +$6.31K ﹤0.01% 1566
2020
Q3 		– Sell
-30,997
Closed -$17K – 910
2020
Q2 		$17K Buy
+30,997
New +$15K ﹤0.01% 633

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Centiva Capital's ASXC Position: Q3 2022 in Review

Centiva Capital sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 14,134 shares — an estimated $6K sold.

Centiva Capital first reported a position in ASXC in Q2 2020 and held it in 2 quarters. The position peaked at $17K in Q2 2020. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

  • Centiva Capital reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 14,134 Asensus Surgical, Inc. shares in Q3 2022, an estimated $6K.
  • Centiva Capital first reported a position in Asensus Surgical, Inc. in Q2 2020 and held it in 2 quarters.
  • Centiva Capital's Asensus Surgical, Inc. position peaked at $17K in Q2 2020.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.